Delveinsight

DECEMBER 29, 2020

However, for geographies other than the US and Canada, Pfizer has received an exclusive right to develop the drug in oncology except in certain Asian countries. Audentes Therapeutics’ ASPIRO Trial Free to Proceed. The clinical hold was put after the death of three enrolled patients during the trial. mg) in the US and Canada.

Trials 52

Trials Drugs Hormones Radiology 52

The Pharma Data

FEBRUARY 21, 2022

We are taking bold steps into the future of drug development, investing strongly in areas at the forefront of the biomedical and technological revolution. Re-imagining Radiology. In particular, AI bears vast potential for advancing radiology.

Radiology 52

Radiology Cardiology Development Production 52

Scienmag

FEBRUARY 16, 2021

Food and Drug Administration (FDA)’s Center for Devices and Radiological Health (CDRH) will participate in this “collaborative community” A medical “collaboratory” is a forum in which multidisciplinary private and public sector members work together on medical […].

Radiology 48

Radiology Drugs Clinical Trials Clinical Trials 48

XTalks

JANUARY 19, 2024

Over the last year, there have been new acquisitions, launches and deals for novel radiotherapeutics and newly created peptide-radioisotope drug conjugates. Currently, several alpha particle emitters are being investigated in clinical trials. In 1997, bismuth-213 was the first alpha emitter to be used clinically.

DNA 66

DNA Radiology FDA Approval Development 66

The Pharma Data

OCTOBER 14, 2020

Michael Felker, MD, MHS, FACC, FAHA, FHFSA is Professor of Medicine with tenure in the Division of Cardiology at Duke University School of Medicine. He is Director of Cardiovascular Research at the Duke Clinical Research Institute and Vice-Chief for Clinical Research in the Division of Cardiology. About Dr. Udelson James E.

Cardiology 40

Cardiology Clinical Trials Clinical Trials Medicine 40